Article info
Correspondence
Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic
- Correspondence to Dr George E Fragoulis, First Department of Propaedeutic Internal Medicine, Joint Rheumatology Program, National and Kapodistrian University of Athens School of Health Sciences, Athens 11527, Greece; geofragoul{at}yahoo.gr
Citation
Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic
Publication history
- Received May 10, 2020
- Accepted May 12, 2020
- First published May 31, 2020.
Online issue publication
March 11, 2021
Article Versions
- Previous version (31 May 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage